MedTrace Logo

Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment Resistant Bipolar Depression

NCT00186485 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2017-10-06

Study results available
· View outcomes & findings →

Summary

We hope to learn whether this stimulation of neurons in the front part of the brain may relieve depression.

Conditions

Interventions

DEVICE

MagStim

The MagStim delivers low frequency 1Hz stimulation to the right frontal area of the brain

Sponsors & Collaborators

Principal Investigators

  • Hugh Brent Solvason · Stanford University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-05-31
Primary Completion
2010-06-30
Completion
2010-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00186485 on ClinicalTrials.gov